Phibro Animal Health (PAHC) Amortization of Deferred Charges (2013 - 2026)

Phibro Animal Health's (PAHC) quarterly Amortization of Deferred Charges came in at $572000.0 in Q1 2026, little changed year-on-year from $572000.0 in Q1 2025, and little changed quarter-over-quarter from $572000.0 in Q4 2025.

Phibro Animal Health (PAHC) Amortization of Deferred Charges (2013 - 2026) Analysis & Trends

Phibro Animal Health's Amortization of Deferred Charges history runs 14 years deep, the most recent figure standing at $572000.0 for Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges changed 0.0% year-over-year to $572000.0 in Q1 2026; TTM through Mar 2026 was $2.3 million, a 34.35% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, up 93.75% from the prior year.
  • Amortization of Deferred Charges steadied at $572000.0 in Q1 2026 per PAHC's latest filing, from $572000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $572000.0 in Q1 2025 and bottomed at $147000.0 in Q1 2022.
  • The 5-year median for Amortization of Deferred Charges is $260000.0 (2023), against an average of $340764.7.
  • Across the five-year window, Amortization of Deferred Charges slumped 33.48% in 2022 and surged 120.0% in 2025, its largest moves.
  • Year by year, Amortization of Deferred Charges stood at $179000.0 in 2022, then soared by 45.25% to $260000.0 in 2023, then surged by 93.85% to $504000.0 in 2024, then climbed by 13.49% to $572000.0 in 2025, then changed by 0.0% to $572000.0 in 2026.
  • Per Business Quant, the three latest PAHC Amortization of Deferred Charges figures stand at $572000.0 (Q1 2026), $572000.0 (Q4 2025), and $572000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.15 Bn 87.28 Bn -
2 Teva Pharmaceutical Industries 35.91 Bn 32.16 Bn 1.97 Bn
3 Zoetis 32.68 Bn 30.74 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.59 Bn 23.53 Bn 4.39 Bn
5 United Therapeutics 23.21 Bn 21.06 Bn 648.10 Mn
6 RedHill Biopharma 20.54 Bn 20.54 Bn -
7 Viatris 20.31 Bn 18.50 Bn 1.16 Bn
8 Neurocrine Biosciences 17.83 Bn 16.51 Bn 800.70 Mn
9 Elanco Animal Health 12.60 Bn 12.17 Bn 785.00 Mn
10 Phibro Animal Health 1.42 Bn 1.34 Bn 125.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 572,000.00
Mar 31, 2026 572,000.00
Dec 31, 2025 572,000.00
Dec 31, 2025 572,000.00
Sep 30, 2025 572,000.00
Sep 30, 2025 572,000.00
Jun 30, 2025 572,000.00
Jun 30, 2025 572,000.00
Mar 31, 2025 572,000.00
Mar 31, 2025 572,000.00
Dec 31, 2024 504,000.00
Dec 31, 2024 504,000.00
Sep 30, 2024 367,000.00
Sep 30, 2024 367,000.00
Jun 30, 2024 260,000.00
Jun 30, 2024 260,000.00
Mar 31, 2024 260,000.00
Mar 31, 2024 260,000.00
Dec 31, 2023 260,000.00
Dec 31, 2023 260,000.00